Duvelisib
Back to searchMolecule Structure
Scientific Name
Duvelisib
Description of the Drug
Duvelisib is an inhibitor of phosphatidylinositol 3-kinase delta and gamma used to treat relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11952
http://www.drugbank.ca/drugs/DB11952
Brand Name(s)
Copiktra
Company Owner(s)
Secura Bio Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| PI3-kinase p110-gamma subunit | SINGLE PROTEIN | INHIBITOR | CHEMBL3267 |
| PI3-kinase p110-delta subunit | SINGLE PROTEIN | INHIBITOR | CHEMBL3130 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL20580104 | SCHEMBL153543 | SCHEMBL18343557 |
| DrugBank | DB11952 | ||
| PubChem: Thomson Pharma | 111324357 | ||
| PubChem | 50905713 | ||
| LINCS | LSM-42769 | ||
| BindingDB | 50193013 | ||
| EPA CompTox Dashboard | DTXSID80152697 | ||
| DrugCentral | 5296 | ||
| ChemicalBook | CB32645143 | ||
| Guide to Pharmacology | 7795 | ||
| rxnorm | DUVELISIB | COPIKTRA | |
| ChEBI | 131169 | ||
| ZINC | ZINC000088346058 |
